Suppr超能文献

测序平台对使用Hawk-Seq™进行化学突变检测灵敏度的影响。

Effect of sequencing platforms on the sensitivity of chemical mutation detection using Hawk-Seq™.

作者信息

Hosoi Sayaka, Hirose Takako, Matsumura Shoji, Otsubo Yuki, Saito Kazutoshi, Miyazawa Masaaki, Suzuki Takayoshi, Masumura Kenichi, Sugiyama Kei-Ichi

机构信息

R&D - Safety Science Research, Kao Corporation, 3-25-14 Tonomachi, Kawasaki-ku, Kawasaki-shi, Kanagawa, 210-0821, Japan.

R&D - Safety Science Research, Kao Corporation, 2606 Akabane, Ichikai-Machi, Haga-Gun, Tochigi, 321-3497, Japan.

出版信息

Genes Environ. 2024 Oct 9;46(1):20. doi: 10.1186/s41021-024-00313-9.

Abstract

BACKGROUND

Error-corrected next-generation sequencing (ecNGS) technologies have enabled the direct evaluation of genome-wide mutations after exposure to mutagens. Previously, we reported an ecNGS methodology, Hawk-Seq™, and demonstrated its utility in evaluating mutagenicity. The evaluation of technical transferability is essential to further evaluate the reliability of ecNGS-based assays. However, cutting-edge sequencing platforms are continually evolving, which can affect the sensitivity of ecNGS. Therefore, the effect of differences in sequencing instruments on mutation data quality should be evaluated.

RESULTS

We assessed the performance of four sequencing platforms (HiSeq2500, NovaSeq6000, NextSeq2000, and DNBSEQ-G400) with the Hawk-Seq™ protocol for mutagenicity evaluation using DNA samples from mouse bone marrow exposed to benzo[a]pyrene (BP). The overall mutation (OM) frequencies per 10 bp in vehicle-treated samples were 0.22, 0.36, 0.46, and 0.26 for HiSeq2500, NovaSeq6000, NextSeq2000, and DNBSEQ-G400, respectively. The OM frequency of NextSeq2000 was significantly higher than that of HiSeq2500, suggesting the difference to be based on the platform. The relatively higher value in NextSeq2000 was a consequence of the G:C to C:G mutations in NextSeq2000 data (0.67 per 10 G:C bp), which was higher than the mean of the four platforms by a ca. of 0.25 per 10 G:C bp. A clear dose-dependent increase in G:C to T:A mutation frequencies was observed in all four sequencing platforms after BP exposure. The cosine similarity values of the 96-dimensional trinucleotide mutation patterns between HiSeq and the three other platforms were 0.93, 0.95, and 0.92 for NovaSeq, NextSeq, and DNBSeq, respectively. These results suggest that all platforms can provide equivalent data that reflect the characteristics of the mutagens.

CONCLUSIONS

All platforms sensitively detected mutagen-induced mutations using the Hawk-Seq™ analysis. The substitution types and frequencies of the background errors differed depending on the platform. The effects of sequencing platforms on mutagenicity evaluation should be assessed before experimentation.

摘要

背景

纠错下一代测序(ecNGS)技术能够直接评估暴露于诱变剂后全基因组的突变情况。此前,我们报道了一种ecNGS方法Hawk-Seq™,并证明了其在评估致突变性方面的实用性。评估技术可转移性对于进一步评估基于ecNGS的检测方法的可靠性至关重要。然而,前沿测序平台不断发展,这可能会影响ecNGS的灵敏度。因此,应评估测序仪器差异对突变数据质量的影响。

结果

我们使用暴露于苯并[a]芘(BP)的小鼠骨髓DNA样本,采用Hawk-Seq™方案评估了四种测序平台(HiSeq2500、NovaSeq6000、NextSeq2000和DNBSEQ-G400)在致突变性评估方面的性能。在溶剂处理样本中,HiSeq2500、NovaSeq6000、NextSeq2000和DNBSEQ-G400每10 bp的总突变(OM)频率分别为0.22、0.36、0.46和0.26。NextSeq2000的OM频率显著高于HiSeq2500,表明差异基于平台。NextSeq2000中相对较高的值是由于NextSeq2000数据中G:C到C:G的突变(每10个G:C bp中有0.67个),比四个平台的平均值高约每10个G:C bp 0.25个。在BP暴露后,所有四个测序平台均观察到G:C到T:A突变频率呈明显的剂量依赖性增加。HiSeq与其他三个平台之间96维三核苷酸突变模式的余弦相似性值,NovaSeq、NextSeq和DNBSeq分别为0.93、0.95和0.92。这些结果表明,所有平台都能提供反映诱变剂特征的等效数据。

结论

所有平台使用Hawk-Seq™分析均能灵敏地检测到诱变剂诱导的突变。背景错误的替换类型和频率因平台而异。在实验前应评估测序平台对致突变性评估的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/47a5/11462924/8aaec015df7c/41021_2024_313_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验